Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

This research article is the science behind the headlines " Breast cancer: Test means fewer women will need chemotherapy " . The research concludes that the recurrence score based on the 21-gene breast cancer assay predicts chemotherapy benefit if it is high and a low risk of recurrence in the absence of chemotherapy if it is low; however, there is uncertainty about the benefit of chemotherapy for most patients, who have a midrange score.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news